Neumora Therapeutics (NMRA) Return on Assets [ROA] (2023 - 2026)
Neumora Therapeutics (NMRA) reported Return on Assets [ROA] of -152.44% for Q2 2026, down 47.53 percentage points from -104.91% a year earlier and down 23.48 percentage points from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Neumora Therapeutics posted Return on Assets [ROA] of -93.28%, down 33.32 percentage points from FY2024.
- By year, Return on Assets [ROA] came in at -59.96% in FY2024 (-8.81 pp) and -51.15% in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] in data going back to Q4 2023.
- Year over year, Return on Assets [ROA] has now declined in each of the last seven quarters, with an average year-over-year change of -40.90 percentage points over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -128.95% (Q1 2026), -128.46% (Q4 2025) and -117.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Neumora Therapeutics | 103.34 Mn | 103.34 Mn | - | -152.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -152.44% |
| Mar 31, 2026 | -128.95% |
| Dec 31, 2025 | -128.46% |
| Sep 30, 2025 | -117.66% |
| Jun 30, 2025 | -104.91% |
| Mar 31, 2025 | -89.96% |
| Dec 31, 2024 | -72.83% |
| Sep 30, 2024 | -77.52% |
| Jun 30, 2024 | -64.10% |
| Mar 31, 2024 | -53.62% |
| Dec 31, 2023 | -45.96% |
API Access
Neumora Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();